60 Degrees Pharmaceutical... (SXTP)
NASDAQ: SXTP
· Real-Time Price · USD
1.40
-0.04 (-2.64%)
At close: Oct 03, 2025, 3:59 PM
1.42
1.43%
After-hours: Oct 03, 2025, 04:38 PM EDT
60 Degrees Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Revenue | 960.89K | 778.72K | 668.53K | 449.79K | 365.69K | 299.52K | 170.6K | 52.24K | 169.24K | 154.88K | 184.73K | 289.85K | 121.66K | 76.49K | 29.46K |
Cost of Revenue | 353.09K | 392.6K | 384.76K | 412.94K | 372.45K | 466.87K | 474.55K | 452.65K | 473.74K | 376.88K | 393.89K | 341.15K | 248.87K | 161.75K | 71.62K |
Gross Profit | 277.54K | 262.79K | 253.17K | 36.85K | 76.21K | -84.37K | -220.98K | -317.44K | -304.5K | -222K | -209.16K | -51.31K | -127.21K | -85.27K | -42.16K |
Operating Income | -7.71M | -10.29M | -9.71M | -9.53M | -8.94M | -5.54M | -5.15M | -3.95M | -2.64M | -2.54M | -1.75M | -1.55M | -1.33M | -645.6K | -481.89K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -7.82M | -10.26M | -7.96M | -7.95M | -1.62M | -788.03K | -3.81M | -3.69M | -9.31M | -8.12M | -6.43M | -5.87M | -4.42M | -2.27M | -1.36M |
Net Income | -7.8M | -10.25M | -7.95M | -7.91M | -1.57M | -735.17K | -3.77M | -3.68M | -9.31M | -8.12M | -6.43M | -5.87M | -4.42M | -2.27M | -1.36M |
Selling & General & Admin | 6.12M | 5.64M | 5.02M | 5.11M | 5.21M | 4.54M | 4.24M | 3.02M | 2.12M | 2.06M | 1.46M | 1.26M | 843.7K | 437.86K | 263.17K |
Research & Development | 2.21M | 5.06M | 4.99M | 4.47M | 3.8M | 904.96K | 691.77K | 795.03K | 558.98K | 586.5K | 525.56K | 755.85K | 728.19K | 496.8K | 433.74K |
Other Expenses | -105.55K | -105.55K | -12.82K | -12.82K | n/a | -3.12K | -7.41K | -20.84K | -171.1K | -160.24K | -273.1K | -516.85K | -366.59K | -374.33K | -257.18K |
Operating Expenses | 8.23M | 10.59M | 10M | 9.57M | 9.01M | 5.44M | 4.93M | 3.62M | 2.33M | 2.32M | 1.6M | 1.37M | 1.08M | 437.86K | 263.17K |
Interest Expense | 5.9K | 8.3K | 7.91K | 11.94K | 50.58K | 1.15M | 2.29M | 3.39M | 4.56M | 4.37M | 3.99M | 3.8M | 2.59M | 1.68M | 921.04K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.68M | 11.09M | 10.4M | 10M | 9.38M | 5.91M | 5.4M | 4.07M | 2.81M | 2.69M | 1.94M | 1.8M | 1.42M | 683.59K | 472.85K |
Income Tax Expense | 1.31K | 250.00 | 250.00 | 812.00 | 625.00 | 250.00 | 250.00 | -61 | 126.00 | 313.00 | 500.00 | 1K | 750.00 | 500.00 | 250.00 |
Shares Outstanding (Basic) | 1.47M | 1.28M | 454.58K | 2.44M | 986.9K | 168.76K | 5.81M | 5.8M | 5.8M | 5.57M | 5.57M | 5.57M | 5.57M | 96.83K | 5.81M |
Shares Outstanding (Diluted) | 1.47M | 1.28M | 454.58K | 2.44M | 1.01M | 168.76K | 5.81M | 5.8M | 5.8M | 5.57M | 5.57M | 5.57M | 5.57M | 96.83K | 5.81M |
EPS (Basic) | -8.19 | -11.17 | -7.78 | -3.62 | -2.02 | 1.63 | -0.67 | -0.68 | -1.66 | -1.47 | -2.97 | -2.85 | -2.59 | -2.2 | -0.23 |
EPS (Diluted) | -8.19 | -11.05 | -7.66 | -3.5 | -1.9 | 1.63 | -0.67 | -0.68 | -1.66 | -1.47 | -2.97 | -2.85 | -2.59 | -2.2 | -0.23 |
EBITDA | -7.64M | -10.19M | -7.88M | -7.87M | -1.49M | 454.57K | -1.43M | -200.63K | -4.65M | -3.66M | -2.36M | -1.99M | -1.78M | -551.49K | -425.33K |
EBIT | -7.81M | -10.25M | -7.95M | -7.94M | -1.57M | 358.58K | -1.53M | -298.96K | -4.75M | -3.75M | -2.44M | -2.07M | -1.83M | -588.69K | -443.71K |
Depreciation & Amortization | 67.08K | 58.41K | 63.74K | 71.24K | 82.02K | 96K | 100.37K | 98.34K | 92.34K | 86.47K | 78.79K | 75.76K | 56.33K | 37.2K | 18.38K |